1. Heeke, Arielle L, Pishvaian, Michael J, Lynce, Filipa, Marshall, John L, Isaacs, Claudine. 2018. Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. In JCO precision oncology, 2018, . doi:10.1200/PO.17.00286. https://pubmed.ncbi.nlm.nih.gov/30234181/
2. Toh, MingRen, Ngeow, Joanne. 2021. Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications. In The oncologist, 26, e1526-e1537. doi:10.1002/onco.13829. https://pubmed.ncbi.nlm.nih.gov/34021944/
3. Ray Chaudhuri, Arnab, Callen, Elsa, Ding, Xia, Sharan, Shyam K, Nussenzweig, André. . Replication fork stability confers chemoresistance in BRCA-deficient cells. In Nature, 535, 382-7. doi:10.1038/nature18325. https://pubmed.ncbi.nlm.nih.gov/27443740/
4. Elkholi, Islam E, Di Iorio, Massimo, Fahiminiya, Somayyeh, Rivera, Barbara, Foulkes, William D. 2021. Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer. In Scientific reports, 11, 2409. doi:10.1038/s41598-021-81106-w. https://pubmed.ncbi.nlm.nih.gov/33510186/